English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation Journal article
Li,Licen, Bao,Jiaolin, Wang,Haitao, Lei,Josh Haipeng, Peng,Cheng, Zeng,Jianming, Hao,Wenhui, Zhang,Xu, Xu,Xiaoling, Yu,Chundong, Deng,Chu Xia, Chen,Qiang. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation[J]. Theranostics, 2021, 11(4), 1672-1689.
Authors:  Li,Licen;  Bao,Jiaolin;  Wang,Haitao;  Lei,Josh Haipeng;  Peng,Cheng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:12.4/12.0 | Submit date：2021/03/02
Aib1  Ecm  Hedgehog  Mafb  Pdac  
Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo Conference paper
Ye, Jie, Yuen, Shun Ming, Murphy, Gillian, Xie, Ruiyu, Kwok, Hang Fai. Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo[C], PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS:ELSEVIER SCIENCE BV, 2017, 62-69.
Authors:  Ye, Jie;  Yuen, Shun Ming;  Murphy, Gillian;  Xie, Ruiyu;  Kwok, Hang Fai
Favorite | TC[WOS]:22 TC[Scopus]:23 | Submit date：2018/10/31
Pancreatic Ductal Adenocarcinoma (Pdac)  Adam17  Inhibitory Antibody  Tumorigenesis  Targeted Therapy  
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo Journal article
Ye J., Yuen S.M., Murphy G., Xie R., Kwok H.F.. Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo[J]. European Journal of Pharmaceutical Sciences, 2017, 110, 62-69.
Authors:  Ye J.;  Yuen S.M.;  Murphy G.;  Xie R.;  Kwok H.F.
Favorite | TC[WOS]:22 TC[Scopus]:23  IF:4.3/4.2 | Submit date：2018/12/19
Adam17  Inhibitory Antibody  Pancreatic Ductal Adenocarcinoma (Pdac)  Targeted Therapy  Tumorigenesis  
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 Journal article
Ye, J., Yuen, S. M., Murphy, G., Xie, R., Kwok, H. F.. Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17[J]. European Journal of Pharmaceutical Sciences, 2017, 62-69.
Authors:  Ye, J.;  Yuen, S. M.;  Murphy, G.;  Xie, R.;  Kwok, H. F.
Favorite |   IF:4.3/4.2 | Submit date：2022/06/02
Pancreatic Ductal Adenocarcinoma (Pdac)  Adam17  Inhibitory Antibody  Tumorigenesis  Targeted Therapy